Cambridge Healthtech Institute’s Inaugural
Advances in Immunoengineering
Modulating Immune Responses
11 November 2025
Cambridge Healthtech Institute's Inaugural Advances in Immunoengineering conference offers insights into the field of immunoengineering, with breakthrough approaches in modulating immune responses in oncology, autoimmunity and beyond. Join industry experts and researchers to discuss cutting-edge advances in immune cell engineering, tumour microenvironment targeting, spatial omics applications, and AI-driven immune modulation. This conference will provide a comprehensive look at engineering the next frontier in immunotherapeutics.
Coverage will include, but is not limited to:
Novel Approaches in Tumour Biology
- Immune biology in solid tumors
- Spatial Omics
- Immunopeptidomics applications
- Decoding the epiProteome
- Microbiome influence in cancer treatments and prognosis
Modulating the Tumour Microenvironment
- Addressing resistance mechanisms
- Targeting immune suppressive myeloid populations
Engineering Immune Cell Therapies
- CAR-T cell optimisation and next generation designs
- NK cell engineering for enhanced tumour targeting
- Gammadelta T cell engineering
- Macrophage engineering for cancer and autoimmunity
- Strategies to enhance CAR T cell persistence
- Addressing antigen escape in engineered cell therapies
- Overcoming T cell exhaustion in solid tumours
AIML Approaches in Immune Modulation
- ML in cellular therapeutics
- Computational modeling of immune cell interactions
- Computational modeling of T cell signaling networks, epitope prediction and TCR design
The deadline for priority consideration is 28 March 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: